+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Multivalent Oral Rotavirus Vaccine Market - Global Forecast 2026-2032- Product Image
Multivalent Oral Rotavirus Vaccine Market - Global Forecast 2026-2032- Product Image
Sale

Multivalent Oral Rotavirus Vaccine Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6123814
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Multivalent Oral Rotavirus Vaccine Market is projected to reach USD 1.50 Billion in 2026. It is expected to continue growing at a CAGR of 7.33%, reaching USD 2.28 Billion by 2032.

Multivalent Oral Rotavirus Vaccines: Executive Summary

Multivalent oral rotavirus vaccines are designed to protect against multiple rotavirus serotypes through oral administration. Their public-health relevance reflects the substantial burden of rotavirus gastroenteritis among infants and young children, particularly where timely access to clinical care, oral rehydration, and sanitation is uneven. Product performance and program value depend on serotype coverage, dosing schedules, cold-chain reliability, vaccine safety, and integration with routine childhood immunization.

Program Design Is Shifting Toward Delivery Resilience

The landscape is being reshaped by efforts to improve routine immunization completion, reduce missed doses, and maintain vaccine delivery during outbreaks, conflict, disasters, and health-system disruption. Oral presentation can simplify administration in settings where trained injection providers are scarce, while multidose schedules make appointment tracking and caregiver communication important. Procurement decisions increasingly consider evidence across age groups, local epidemiology, supply continuity, storage requirements, wastage, and compatibility with national immunization schedules.

Artificial Intelligence Supports Surveillance, Planning, and Quality Control

Artificial intelligence can strengthen rotavirus-vaccine programs by identifying immunization gaps from health-record and registry data, improving demand planning, and prioritizing outreach to communities with low coverage. Machine-learning tools may also support genomic and clinical surveillance, signal detection, cold-chain monitoring, and quality-assurance workflows. These applications require representative data, validation against epidemiological outcomes, privacy safeguards, cybersecurity, and human oversight; AI should augment, rather than replace, regulatory review and public-health judgment.

Regional Insights: Delivery Conditions Shape Vaccine Impact

North America and Europe generally benefit from established immunization infrastructure, but maintaining high completion rates and addressing underserved populations remain central priorities. Latin America’s programs are influenced by urban-rural disparities, fiscal capacity, and regional procurement coordination. The Middle East and Africa face varied conditions across countries, including conflict-related disruption, supply-chain constraints, and uneven access to primary care. Asia-Pacific combines large birth cohorts and diverse health systems with strong opportunities for routine-program expansion, local manufacturing, and digital coverage monitoring. Across all regions, evidence on local disease patterns and operational feasibility is essential.

Group Insights: Alliances Can Improve Coordination and Equity

ASEAN countries may benefit from coordinated procurement, shared surveillance, and approaches tailored to archipelagic and rural delivery settings. BRICS members span differing epidemiological profiles and manufacturing capabilities, creating opportunities for technology collaboration while requiring careful alignment of regulatory and program standards. The European Union can leverage coordinated scientific assessment and cross-border health cooperation, whereas G7 members can support evidence generation, financing, and resilient supply chains. GCC states typically have comparatively strong clinical infrastructure but must sustain coverage among mobile and expatriate populations. NATO members may apply logistics and continuity planning capabilities to protect childhood immunization during emergencies.

Country Insights: National Priorities Differ Across Delivery Systems

Australia, Canada, France, Germany, Italy, Japan, South Korea, Spain, the United Kingdom, and the United States must sustain routine coverage while addressing access gaps, hesitancy, and population mobility. Brazil, India, Mexico, and Russia face the additional challenge of managing geographically diverse delivery environments and ensuring consistent access beyond major urban centers. China combines extensive immunization infrastructure with the need for rigorous surveillance and equitable access across provinces. Across these countries, decision-makers should evaluate product suitability alongside schedule adherence, pharmacovigilance, cold-chain performance, procurement resilience, and transparent communication with caregivers.

Actions for Leaders: Build Evidence, Resilience, and Trust

Industry and public-health leaders should align product development with national schedules and documented serotype epidemiology; generate robust safety and effectiveness evidence in relevant populations; and design packaging, dosing guidance, and training around real-world delivery constraints. They should diversify critical inputs, strengthen temperature monitoring, and establish continuity plans for disruptions. Partnerships with immunization programs can improve coverage measurement and caregiver education, while responsible digital and AI deployment should include data governance, independent validation, and clear accountability. Transparent communication about benefits, limitations, and adverse-event monitoring is essential for sustained confidence.

Research Methodology: Evidence-Led Market Assessment

This executive summary uses the defined market scope of multivalent oral rotavirus vaccines and synthesizes public-health, immunization-policy, epidemiological, regulatory, and delivery-system considerations. A rigorous assessment should triangulate peer-reviewed studies, national immunization guidance, regulatory documents, surveillance reports, procurement materials, and implementation research. Regional, group, and country comparisons should be interpreted cautiously because reporting practices, schedules, eligibility rules, health-system capacity, and rotavirus epidemiology differ. Claims should be retained only when supported by authoritative and current evidence, with uncertainty documented rather than inferred.

Conclusion: Program Fit Determines Real-World Value

Multivalent oral rotavirus vaccines can contribute meaningfully to child-health strategies when they are matched to local epidemiology, immunization schedules, delivery capacity, and affordability constraints. The strongest programs will combine dependable supply and cold-chain operations with accurate coverage data, effective caregiver engagement, active safety monitoring, and equitable access. Artificial intelligence may improve planning and surveillance, but its value depends on data quality and governance. Leaders should therefore prioritize evidence-based product selection and resilient routine immunization systems over isolated technological or commercial considerations.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Multivalent Oral Rotavirus Vaccine Market, by Vaccine Type
7.1. Introduction
7.2. Monovalent
7.3. Pentavalent
8. Multivalent Oral Rotavirus Vaccine Market, by Dosage Form
8.1. Introduction
8.2. Lyophilized Powder
8.3. Liquid Oral Suspension
9. Multivalent Oral Rotavirus Vaccine Market, by Vaccine Platform
9.1. Introduction
9.2. Live Attenuated
9.2.1. Human Neonatal Strain
9.2.2. Human Non-Neonatal Strain
9.2.3. Animal-Human Reassortant
9.3. Inactivated
9.3.1. Whole Virus
9.3.2. Split Or Subunit
9.4. Novel Oral Platforms
9.4.1. Virus Like Particle
9.4.2. Vector Based
9.4.3. RNA Based Oral Delivery
10. Multivalent Oral Rotavirus Vaccine Market, by End User Type
10.1. Introduction
10.2. Public Health Facilities
10.2.1. Public Hospitals
10.2.2. Maternal And Child Health Clinics
10.2.3. Community Health Centers
10.3. Private Healthcare Providers
10.3.1. Private Pediatric Clinics
10.3.2. Private Hospitals
10.3.3. Multi-Specialty Clinics
10.4. Retail And Alternative Settings
10.4.1. Retail Pharmacies And Drugstores
10.4.2. Mobile Or Outreach Clinics
10.4.3. Non-Governmental Health Organizations
11. Multivalent Oral Rotavirus Vaccine Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Multivalent Oral Rotavirus Vaccine Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Multivalent Oral Rotavirus Vaccine Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Bharat Biotech International Limited
15.2. Bio Farma
15.3. Biological E. Limited
15.4. Cadila Healthcare Limited
15.5. GlaxoSmithKline plc
15.6. Hilleman Laboratories
15.7. Indian Immunologicals Limited
15.8. Lanzhou Institute of Biological Products Co., Ltd.
15.9. Merck & Co., Inc.
15.10. Panacea Biotec Ltd.
15.11. Pfizer Inc.
15.12. Sanofi S.A.
15.13. Serum Institute of India Pvt. Ltd.
15.14. Shantha Biotechnics
15.15. Sinovac Biotech Ltd.
15.16. Takeda Pharmaceutical Company Limited
15.17. Valneva SE
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Multivalent Oral Rotavirus Vaccine Market, Years Considered for the Study
FIGURE 2. Global Multivalent Oral Rotavirus Vaccine Market, Research Design
FIGURE 3. Global Multivalent Oral Rotavirus Vaccine Market, Research Framework
FIGURE 4. Global Multivalent Oral Rotavirus Vaccine Market, Data Triangulation
FIGURE 5. Global Multivalent Oral Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2025 vs 2032 (%)
FIGURE 7. Global Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 9. Global Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2025 vs 2032 (%)
FIGURE 11. Global Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2025 vs 2032 (%)
FIGURE 13. Global Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Multivalent Oral Rotavirus Vaccine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Multivalent Oral Rotavirus Vaccine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Multivalent Oral Rotavirus Vaccine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Multivalent Oral Rotavirus Vaccine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Multivalent Oral Rotavirus Vaccine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Multivalent Oral Rotavirus Vaccine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Multivalent Oral Rotavirus Vaccine Market Segmentation & Coverage
TABLE 2. Global Multivalent Oral Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 3. Global Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 4. Global Monovalent Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Monovalent Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Monovalent Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Pentavalent Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Pentavalent Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Pentavalent Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 11. Global Lyophilized Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Lyophilized Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Lyophilized Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Liquid Oral Suspension Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Liquid Oral Suspension Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Liquid Oral Suspension Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 18. Global Live Attenuated Market Size, by Region, 2017-2032 (USD Million)
TABLE 19. Global Live Attenuated Market Size, by Group, 2017-2032 (USD Million)
TABLE 20. Global Live Attenuated Market Size, by Country, 2017-2032 (USD Million)
TABLE 21. Global Human Neonatal Strain Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Human Neonatal Strain Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Human Neonatal Strain Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Human Non-Neonatal Strain Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Human Non-Neonatal Strain Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Human Non-Neonatal Strain Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Animal-Human Reassortant Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Animal-Human Reassortant Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Animal-Human Reassortant Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Inactivated Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Inactivated Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Inactivated Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Whole Virus Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Whole Virus Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Whole Virus Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Split Or Subunit Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Split Or Subunit Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Split Or Subunit Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Novel Oral Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Novel Oral Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Novel Oral Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Virus Like Particle Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Virus Like Particle Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Virus Like Particle Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Vector Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Vector Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Vector Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global RNA Based Oral Delivery Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global RNA Based Oral Delivery Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global RNA Based Oral Delivery Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 52. Global Public Health Facilities Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Public Health Facilities Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Public Health Facilities Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Maternal And Child Health Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Maternal And Child Health Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Maternal And Child Health Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Community Health Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Community Health Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Community Health Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Private Healthcare Providers Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Private Healthcare Providers Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Private Healthcare Providers Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Private Pediatric Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Private Pediatric Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Private Pediatric Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Multi-Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Multi-Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Multi-Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Retail And Alternative Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Retail And Alternative Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Retail And Alternative Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Retail Pharmacies And Drugstores Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Retail Pharmacies And Drugstores Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Retail Pharmacies And Drugstores Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Mobile Or Outreach Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Mobile Or Outreach Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Mobile Or Outreach Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Non-Governmental Health Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Non-Governmental Health Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Non-Governmental Health Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Multivalent Oral Rotavirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Multivalent Oral Rotavirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 100. North America Multivalent Oral Rotavirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. North America Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 102. North America Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 103. North America Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 104. North America Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 105. North America Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 106. North America Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 107. North America Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 108. North America Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 109. North America Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 110. North America Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 111. Latin America Multivalent Oral Rotavirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Latin America Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 113. Latin America Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 114. Latin America Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 115. Latin America Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 116. Latin America Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 117. Latin America Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 118. Latin America Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 119. Latin America Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 120. Latin America Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 121. Latin America Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 122. Europe Multivalent Oral Rotavirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Europe Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 124. Europe Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 125. Europe Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 126. Europe Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 127. Europe Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 128. Europe Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 129. Europe Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 130. Europe Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 131. Europe Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 132. Europe Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 133. Middle East Multivalent Oral Rotavirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Middle East Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 135. Middle East Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 136. Middle East Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 137. Middle East Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 138. Middle East Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 139. Middle East Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 140. Middle East Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 141. Middle East Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 142. Middle East Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 143. Middle East Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 144. Africa Multivalent Oral Rotavirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Africa Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 146. Africa Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 147. Africa Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 148. Africa Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 149. Africa Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 150. Africa Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 151. Africa Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 152. Africa Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 153. Africa Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 154. Africa Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 155. Global Multivalent Oral Rotavirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. ASEAN Multivalent Oral Rotavirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. ASEAN Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 158. ASEAN Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 159. ASEAN Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 160. ASEAN Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 161. ASEAN Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 162. ASEAN Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 163. ASEAN Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 164. ASEAN Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 165. ASEAN Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 166. ASEAN Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 167. GCC Multivalent Oral Rotavirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. GCC Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 169. GCC Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 170. GCC Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 171. GCC Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 172. GCC Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 173. GCC Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 174. GCC Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 175. GCC Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 176. GCC Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 177. GCC Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 178. European Union Multivalent Oral Rotavirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. European Union Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 180. European Union Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 181. European Union Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 182. European Union Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 183. European Union Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 184. European Union Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 185. European Union Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 186. European Union Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 187. European Union Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 188. European Union Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 189. BRICS Multivalent Oral Rotavirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. BRICS Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 191. BRICS Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 192. BRICS Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 193. BRICS Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 194. BRICS Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 195. BRICS Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 196. BRICS Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 197. BRICS Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 198. BRICS Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 199. BRICS Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 200. G7 Multivalent Oral Rotavirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 201. G7 Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 202. G7 Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 203. G7 Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 204. G7 Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 205. G7 Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 206. G7 Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 207. G7 Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 208. G7 Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 209. G7 Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 210. G7 Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 211. NATO Multivalent Oral Rotavirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 212. NATO Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 213. NATO Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 214. NATO Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 215. NATO Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 216. NATO Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 217. NATO Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 218. NATO Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 219. NATO Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 220. NATO Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 221. NATO Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 222. Global Multivalent Oral Rotavirus Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 223. United States Multivalent Oral Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 224. United States Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 225. United States Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 226. United States Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 227. United States Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 228. United States Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 229. United States Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 230. United States Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 231. United States Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 232. United States Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 233. United States Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 234. Canada Multivalent Oral Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 235. Canada Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 236. Canada Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 237. Canada Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 238. Canada Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 239. Canada Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 240. Canada Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 241. Canada Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 242. Canada Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 243. Canada Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 244. Canada Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 245. Mexico Multivalent Oral Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 246. Mexico Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 247. Mexico Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 248. Mexico Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 249. Mexico Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 250. Mexico Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 251. Mexico Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 252. Mexico Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 253. Mexico Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 254. Mexico Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 255. Mexico Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 256. Brazil Multivalent Oral Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 257. Brazil Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 258. Brazil Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 259. Brazil Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 260. Brazil Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 261. Brazil Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 262. Brazil Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 263. Brazil Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 264. Brazil Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 265. Brazil Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 266. Brazil Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 267. United Kingdom Multivalent Oral Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 268. United Kingdom Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 269. United Kingdom Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 270. United Kingdom Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 271. United Kingdom Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 272. United Kingdom Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 273. United Kingdom Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 274. United Kingdom Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 275. United Kingdom Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 276. United Kingdom Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 277. United Kingdom Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 278. Germany Multivalent Oral Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 279. Germany Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 280. Germany Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 281. Germany Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 282. Germany Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 283. Germany Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 284. Germany Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 285. Germany Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 286. Germany Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 287. Germany Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 288. Germany Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 289. France Multivalent Oral Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 290. France Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 291. France Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 292. France Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 293. France Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 294. France Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 295. France Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 296. France Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 297. France Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 298. France Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2017-2032 (USD Million)
TABLE 299. France Multivalent Oral Rotavirus Vaccine Market Size, by Retail And Alternative Settings, 2017-2032 (USD Million)
TABLE 300. Russia Multivalent Oral Rotavirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 301. Russia Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 302. Russia Multivalent Oral Rotavirus Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 303. Russia Multivalent Oral Rotavirus Vaccine Market Size, by Vaccine Platform, 2017-2032 (USD Million)
TABLE 304. Russia Multivalent Oral Rotavirus Vaccine Market Size, by Live Attenuated, 2017-2032 (USD Million)
TABLE 305. Russia Multivalent Oral Rotavirus Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 306. Russia Multivalent Oral Rotavirus Vaccine Market Size, by Novel Oral Platforms, 2017-2032 (USD Million)
TABLE 307. Russia Multivalent Oral Rotavirus Vaccine Market Size, by End User Type, 2017-2032 (USD Million)
TABLE 308. Russia Multivalent Oral Rotavirus Vaccine Market Size, by Public Health Facilities, 2017-2032 (USD Million)
TABLE 309. Russia Multivalent Oral Rotavirus Vaccine Market Size, by Private Healthcare Providers, 2

Companies Mentioned

  • Bharat Biotech International Limited
  • Bio Farma
  • Biological E. Limited
  • Cadila Healthcare Limited
  • GlaxoSmithKline plc
  • Hilleman Laboratories
  • Indian Immunologicals Limited
  • Lanzhou Institute of Biological Products Co., Ltd.
  • Merck & Co., Inc.
  • Panacea Biotec Ltd.
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • Shantha Biotechnics
  • Sinovac Biotech Ltd.
  • Takeda Pharmaceutical Company Limited
  • Valneva SE

Related Topics

Related Reports

Rotavirus Vaccine Market Strategic Outlook & Competitive Landscape (2026-2031) - Product Image

Rotavirus Vaccine Market Strategic Outlook & Competitive Landscape (2026-2031)

  • Report
  • 99 Pages
  • Global
From
Rotavirus Vaccine Market - Global Forecast 2026-2032 - Product Image

Rotavirus Vaccine Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Rotavirus Vaccine Market Report 2026 - Product Image

Rotavirus Vaccine Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Rotavirus Vaccines Market - Global Strategic Business Report - Product Image

Rotavirus Vaccines Market - Global Strategic Business Report

  • Report
  • 277 Pages
  • Global
From
Rotavirus Vaccine Market Outlook 2026-2034: Market Share and Growth Analysis - Product Image

Rotavirus Vaccine Market Outlook 2026-2034: Market Share and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.